Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Foti SC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    Pathological substrate of memory impairment in multiple system atrophy.
    Autorzy:
    Miki Y; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Tanji K; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Shinnai K; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Tanaka MT; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.; Faculty of Science and Engineering, Graduate School of Science and Engineering, Iwate University, Morioka, Japan.
    Altay F; Laboratory of Molecular and Chemical Biology of Neurodegeneration, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
    Foti SC; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Strand C; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Sasaki T; Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Kon T; Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Shimoyama S; Department of Neurophysiology, Institute of Brain Science, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan.
    Furukawa T; Department of Neurophysiology, Institute of Brain Science, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan.
    Nishijima H; Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Yamazaki H; Department of Stress Response Science, Center for Advanced Medical Research, Hirosaki University, Hirosaki, Japan.; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
    Asi YT; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Bettencourt C; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Jaunmuktane Z; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Tada M; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
    Mori F; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Mizukami H; Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Tomiyama M; Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Lashuel HA; Laboratory of Molecular and Chemical Biology of Neurodegeneration, Faculty of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
    Lashley T; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Kakita A; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
    Ling H; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Lees AJ; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Holton JL; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Warner TT; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Wakabayashi K; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Pokaż więcej
    Źródło:
    Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2022 Dec; Vol. 48 (7), pp. e12844. Date of Electronic Publication: 2022 Aug 12.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Multiple System Atrophy*/pathology
    Parkinson Disease*/pathology
    Humans ; alpha-Synuclein/metabolism ; Inclusion Bodies/pathology ; Neurons/pathology ; Brain/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's.
    Autorzy:
    Toomey CE; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK. .; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK. .; The Francis Crick Institute, London, UK. .
    Heywood WE; Translational Mass Spectrometry Research Group, Genetic & Genomic Medicine, Institute of Child Health, UCL, London, UK.
    Evans JR; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.; The Francis Crick Institute, London, UK.
    Lachica J; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
    Pressey SN; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.
    Foti SC; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Al Shahrani M; National Hospital for Neurology and Neurosurgery & Neurometabolic Unit, UCL Great Ormond Street Institute of Child Health, London, UK.; College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
    D'Sa K; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.; The Francis Crick Institute, London, UK.
    Hargreaves IP; National Hospital for Neurology and Neurosurgery & Neurometabolic Unit, UCL Great Ormond Street Institute of Child Health, London, UK.
    Heales S; National Hospital for Neurology and Neurosurgery & Neurometabolic Unit, UCL Great Ormond Street Institute of Child Health, London, UK.
    Orford M; National Hospital for Neurology and Neurosurgery & Neurometabolic Unit, UCL Great Ormond Street Institute of Child Health, London, UK.
    Troakes C; London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
    Attems J; Newcastle Brain Tissue Resource, Institute of Neuroscience and Newcastle University Institute for Ageing, Newcastle upon Tyne, UK.
    Gelpi E; Neurological Tissue Bank, University of Barcelona, Barcelona, Spain.; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
    Palkovits M; Human Brain Tissue Bank, Budapest, Semmelweis University, Budapest, Hungary.
    Lashley T; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Gentleman SM; Department of Brain Sciences, Imperial College London, London, UK.
    Revesz T; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Mills K; Translational Mass Spectrometry Research Group, Genetic & Genomic Medicine, Institute of Child Health, UCL, London, UK.
    Gandhi S; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK. .; The Francis Crick Institute, London, UK. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2022 Sep 08; Vol. 10 (1), pp. 134. Date of Electronic Publication: 2022 Sep 08.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Parkinson Disease*/pathology
    alpha-Synuclein*/metabolism
    Humans ; Mitochondria/metabolism ; Proteome/metabolism ; Proteomics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    MOBP and HIP1 in multiple system atrophy: New α-synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis.
    Autorzy:
    Bettencourt C; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
    Miki Y; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Piras IS; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
    de Silva R; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
    Foti SC; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Talboom JS; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
    Revesz T; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Lashley T; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Balazs R; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Viré E; Institute of Prion Diseases, MRC Prion Unit at UCL, London, UK.
    Warner TT; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
    Huentelman MJ; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
    Holton JL; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
    Pokaż więcej
    Źródło:
    Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2021 Aug; Vol. 47 (5), pp. 640-652. Date of Electronic Publication: 2021 Jan 19.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    DNA-Binding Proteins/*metabolism
    Multiple System Atrophy/*pathology
    Myelin Proteins/*metabolism
    Neuroglia/*pathology
    alpha-Synuclein/*metabolism
    Humans ; Inclusion Bodies/pathology ; Multiple System Atrophy/metabolism ; Myelin Proteins/genetics ; Neuroglia/metabolism ; Oligodendroglia/pathology ; Parkinson Disease/pathology ; White Matter/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Epigenomics and transcriptomics analyses of multiple system atrophy brain tissue supports a role for inflammatory processes in disease pathogenesis.
    Autorzy:
    Bettencourt C; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK. .; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square Brain Bank for Neurological Disorders, 1 Wakefield street, London, WC1N 1PJ, UK. .
    Piras IS; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
    Foti SC; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Talboom J; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
    Miki Y; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
    Lashley T; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Balazs R; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
    Viré E; Institute of Prion Diseases, MRC Prion Unit at UCL, Courtauld Building, 33 Cleveland Street, London, UK.
    Warner TT; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square Brain Bank for Neurological Disorders, 1 Wakefield street, London, WC1N 1PJ, UK.; Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, UK.
    Huentelman MJ; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
    Holton JL; Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square Brain Bank for Neurological Disorders, 1 Wakefield street, London, WC1N 1PJ, UK.
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2020 May 14; Vol. 8 (1), pp. 71. Date of Electronic Publication: 2020 May 14.
    Typ publikacji:
    Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Brain/*pathology
    Encephalitis/*genetics
    Encephalitis/*pathology
    Multiple System Atrophy/*genetics
    Multiple System Atrophy/*pathology
    Encephalitis/complications ; Epigenomics ; Gene Expression Profiling ; Humans ; Multiple System Atrophy/complications
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
    Autorzy:
    Gittings LM; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London, WC1N 1PJ, UK.; UK Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Foti SC; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London, WC1N 1PJ, UK.
    Benson BC; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London, WC1N 1PJ, UK.
    Gami-Patel P; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London, WC1N 1PJ, UK.
    Isaacs AM; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Lashley T; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK. .; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London, WC1N 1PJ, UK. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2019 Feb 12; Vol. 7 (1), pp. 18. Date of Electronic Publication: 2019 Feb 12.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Frontotemporal Lobar Degeneration/*metabolism
    Heterogeneous-Nuclear Ribonucleoproteins/*metabolism
    Hippocampus/*pathology
    RNA-Binding Protein FUS/*metabolism
    Temporal Lobe/*pathology
    Adult ; Aged ; Aged, 80 and over ; Female ; Frontotemporal Lobar Degeneration/pathology ; Hippocampus/metabolism ; Humans ; Inclusion Bodies/metabolism ; Inclusion Bodies/pathology ; Intranuclear Inclusion Bodies/metabolism ; Intranuclear Inclusion Bodies/pathology ; Male ; Middle Aged ; Temporal Lobe/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies